Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 1/10

vs
industry
vs
history
Cash-to-Debt 0.01
AMRS's Cash-to-Debt is ranked lower than
99% of the 1126 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.74 vs. AMRS: 0.01 )
Ranked among companies with meaningful Cash-to-Debt only.
AMRS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.56 Max: N/A
Current: 0.01
Equity-to-Asset -2.22
AMRS's Equity-to-Asset is ranked lower than
99% of the 1084 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. AMRS: -2.22 )
Ranked among companies with meaningful Equity-to-Asset only.
AMRS' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.22  Med: -0.48 Max: 0.87
Current: -2.22
-2.22
0.87
Piotroski F-Score: 3
Altman Z-Score: -19.96
Beneish M-Score: -5.39
WACC vs ROIC
13.11%
-722.44%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -135.55
AMRS's Operating Margin % is ranked lower than
96% of the 1106 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.64 vs. AMRS: -135.55 )
Ranked among companies with meaningful Operating Margin % only.
AMRS' s Operating Margin % Range Over the Past 10 Years
Min: -434.9  Med: -230.69 Max: -98.14
Current: -135.55
-434.9
-98.14
Net Margin % -167.31
AMRS's Net Margin % is ranked lower than
97% of the 1106 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.61 vs. AMRS: -167.31 )
Ranked among companies with meaningful Net Margin % only.
AMRS' s Net Margin % Range Over the Past 10 Years
Min: -638.16  Med: -144.86 Max: 5.28
Current: -167.31
-638.16
5.28
ROA % -112.07
AMRS's ROA % is ranked lower than
99% of the 1134 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.66 vs. AMRS: -112.07 )
Ranked among companies with meaningful ROA % only.
AMRS' s ROA % Range Over the Past 10 Years
Min: -135.25  Med: -58.34 Max: 1.1
Current: -112.07
-135.25
1.1
ROC (Joel Greenblatt) % -130.61
AMRS's ROC (Joel Greenblatt) % is ranked lower than
96% of the 1125 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.40 vs. AMRS: -130.61 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMRS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -193.95  Med: -144.21 Max: 25.82
Current: -130.61
-193.95
25.82
3-Year Revenue Growth Rate -22.50
AMRS's 3-Year Revenue Growth Rate is ranked lower than
93% of the 993 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.80 vs. AMRS: -22.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMRS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -52.9 Max: -22.5
Current: -22.5
3-Year EBITDA Growth Rate -59.80
AMRS's 3-Year EBITDA Growth Rate is ranked lower than
99% of the 892 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.50 vs. AMRS: -59.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AMRS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -35.4 Max: -17.7
Current: -59.8
3-Year EPS without NRI Growth Rate -47.90
AMRS's 3-Year EPS without NRI Growth Rate is ranked lower than
97% of the 820 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.40 vs. AMRS: -47.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
AMRS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -37.35 Max: -21.5
Current: -47.9
GuruFocus has detected 4 Warning Signs with Amyris Inc $AMRS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AMRS's 30-Y Financials

Financials (Next Earnings Date: 2017-08-15 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325199    SIC: 2899
Compare:NAS:NTIC, NAS:GURE, OTCPK:LPAD, NAS:SYMX, OTCPK:APGMF, OTCPK:HDGHF, NAS:SNMX, OTCPK:LWLG, OTCPK:PVNNF, OTCPK:NNOMF, NAS:TORM, NAS:AMTX, NAS:TVIA, AMEX:FSI, OTCPK:NANX, OTCPK:ALLM, NAS:DELT, NAS:IKNX, NAS:YTEN, OTCPK:GRPEF » details
Traded in other countries:3A01.Germany,
Headquarter Location:USA
Amyris Inc is an industrial biotechnology company engaged in the engineering, manufacturing, and sales of products in markets such as cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels.

Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States.

Top Ranked Articles about Amyris Inc

Amyris Partners with Queensland on Biofutures Acceleration Program in Next Step Toward Planned Development of Biorefinery
MONDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm
AMRS DEADLINE NOTICE: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important June 19 Deadline in First Filed Class Action - AMRS
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Amyris, Inc. (AMRS) & Lead Plaintiff Deadline - June 19, 2017
The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Amyris, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017
Amyris Announces Reverse Stock Split - Delivering on Strong Product Revenue Growth and Execution
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. - AMRS
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Amyris, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm
Amyris Announces Closing Of First Tranche Of Up To $95 Million In Equity Financing And Conversion Of Over $55 Million Of Debt To Equity

Ratios

vs
industry
vs
history
PS Ratio 0.81
AMRS's PS Ratio is ranked higher than
69% of the 1083 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.36 vs. AMRS: 0.81 )
Ranked among companies with meaningful PS Ratio only.
AMRS' s PS Ratio Range Over the Past 10 Years
Min: 0.53  Med: 3.59 Max: 9.62
Current: 0.81
0.53
9.62
EV-to-EBIT -3.69
AMRS's EV-to-EBIT is ranked lower than
99.99% of the 961 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.91 vs. AMRS: -3.69 )
Ranked among companies with meaningful EV-to-EBIT only.
AMRS' s EV-to-EBIT Range Over the Past 10 Years
Min: -275.9  Med: -2.8 Max: 17.5
Current: -3.69
-275.9
17.5
EV-to-EBITDA -4.33
AMRS's EV-to-EBITDA is ranked lower than
99.99% of the 982 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.09 vs. AMRS: -4.33 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMRS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.2  Med: -2.7 Max: 35.2
Current: -4.33
-27.2
35.2
Current Ratio 0.24
AMRS's Current Ratio is ranked lower than
98% of the 1097 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.85 vs. AMRS: 0.24 )
Ranked among companies with meaningful Current Ratio only.
AMRS' s Current Ratio Range Over the Past 10 Years
Min: 0.16  Med: 1.35 Max: 11.36
Current: 0.24
0.16
11.36
Quick Ratio 0.17
AMRS's Quick Ratio is ranked lower than
98% of the 1097 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.33 vs. AMRS: 0.17 )
Ranked among companies with meaningful Quick Ratio only.
AMRS' s Quick Ratio Range Over the Past 10 Years
Min: 0.09  Med: 1.17 Max: 11.22
Current: 0.17
0.09
11.22
Days Inventory 48.57
AMRS's Days Inventory is ranked higher than
65% of the 1063 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 63.77 vs. AMRS: 48.57 )
Ranked among companies with meaningful Days Inventory only.
AMRS' s Days Inventory Range Over the Past 10 Years
Min: 11.23  Med: 50.01 Max: 139.58
Current: 48.57
11.23
139.58
Days Sales Outstanding 41.54
AMRS's Days Sales Outstanding is ranked higher than
76% of the 890 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 62.22 vs. AMRS: 41.54 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMRS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.75  Med: 23.7 Max: 73.27
Current: 41.54
7.75
73.27
Days Payable 103.06
AMRS's Days Payable is ranked higher than
85% of the 844 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.98 vs. AMRS: 103.06 )
Ranked among companies with meaningful Days Payable only.
AMRS' s Days Payable Range Over the Past 10 Years
Min: 10.32  Med: 62.14 Max: 103.06
Current: 103.06
10.32
103.06

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -52.90
AMRS's 3-Year Average Share Buyback Ratio is ranked lower than
97% of the 570 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -2.10 vs. AMRS: -52.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMRS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -143.6  Med: -32.35 Max: 0
Current: -52.9
-143.6
0

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.22
AMRS's Price-to-Median-PS-Value is ranked higher than
98% of the 1052 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.29 vs. AMRS: 0.22 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMRS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22  Med: 1.14 Max: 2.71
Current: 0.22
0.22
2.71
Earnings Yield (Greenblatt) % -27.00
AMRS's Earnings Yield (Greenblatt) % is ranked lower than
96% of the 1130 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.34 vs. AMRS: -27.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMRS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -500.7  Med: -32.1 Max: 7.6
Current: -27
-500.7
7.6

More Statistics

Revenue (TTM) (Mil) $71.36
EPS (TTM) $ -7.80
Beta-1.31
Short Percentage of Float8.07%
52-Week Range $2.63 - 18.15
Shares Outstanding (Mil)20.76

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 144 216
EPS ($) -3.30 -0.15
EPS without NRI ($) -3.30 -0.15
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for AMRS

Headlines

Articles On GuruFocus.com
Uncovering Value in the Metals and Mining Sector Jun 26 2017 
Boeing Outshines Airbus at the Paris Air Show Jun 26 2017 
Seeking Value in China: Great Wall Motor Jun 26 2017 
Vaccine Small-Cap Just Took a Big Step Forward Jun 26 2017 
Annaly Capital Management: Attractive 9.5% Dividend Yield, but Interest Rates Are a Major Risk Jun 25 2017 
Never a Better Time to Pile on Chipotle Jun 25 2017 
Oracle Slowly Gaining Momentum on the Cloud Front Jun 26 2017 
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 

More From Other Websites
Amyris Partners with Queensland on Biofutures Acceleration Program in Next Step Toward Planned... Jun 20 2017
DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and... Jun 19 2017
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Jun 19 2017
DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Amyris, Inc. of a Class Action Lawsuit... Jun 19 2017
JUNE 19 DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc.... Jun 17 2017
3-DAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and... Jun 16 2017
DEADLINE MONDAY: Levi & Korsinsky, LLP Reminds Shareholders of Amyris, Inc. of a Class Action... Jun 16 2017
MONDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and... Jun 15 2017
AMRS EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving... Jun 15 2017
4-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc.... Jun 15 2017
IMMINENT LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered... Jun 14 2017
DEADLINE ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and... Jun 14 2017
AMRS DEADLINE NOTICE: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important June 19... Jun 14 2017
Law Offices of Howard G. Smith Reminds Amyris, Inc. Investors of Pending Lawsuit and Upcoming Lead... Jun 14 2017
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amyris, Inc. of a Class Action Lawsuit... Jun 14 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Amyris,... Jun 14 2017
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Amyris, Inc. Shareholders... Jun 13 2017
June 19 Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit... Jun 13 2017
ONE WEEK DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc.... Jun 12 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}